Hepatitis Monthly

Published by: Kowsar

Characterization of Serum HBV RNA in Patients with Untreated HBeAg-Positive and -Negative Chronic Hepatitis B Infection

Yutang Li 1 , Lingyuan He 1 , Yao Li 1 , Mingze Su 1 , Jian Su 2 , Jinlin Hou 2 , Juan Deng 1 , Shuai Wang 1 , Qiangyi Wang 1 , Xizhan Xu 1 , Hui Zhuang 1 , * and Tong Li 1 , **
Authors Information
1 Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, Haidian District, Beijing, China
2 Institute of Hepatology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, China
Corresponding Authors:
Article information
  • Hepatitis Monthly: February 2018, 18 (2); e62079
  • Published Online: February 20, 2018
  • Article Type: Research Article
  • Received: September 23, 2017
  • Revised: December 17, 2017
  • Accepted: February 3, 2018
  • DOI: 10.5812/hepatmon.62079

To Cite: Li Y, He L, Li Y, Su M, Su J, et al. Characterization of Serum HBV RNA in Patients with Untreated HBeAg-Positive and -Negative Chronic Hepatitis B Infection, Hepat Mon. 2018 ; 18(2):e62079. doi: 10.5812/hepatmon.62079.

Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45(2):507-39. doi: 10.1002/hep.21513. [PubMed: 17256718].
  • 2. European Association for the Study of the Liver. Electronic address EEE, European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370-98. doi: 10.1016/j.jhep.2017.03.021. [PubMed: 28427875].
  • 3. Jansen L, Kootstra NA, van Dort KA, Takkenberg RB, Reesink HW, Zaaijer HL. Hepatitis B Virus Pregenomic RNA Is Present in Virions in Plasma and Is Associated With a Response to Pegylated Interferon Alfa-2a and Nucleos(t)ide Analogues. J Infect Dis. 2016;213(2):224-32. doi: 10.1093/infdis/jiv397. [PubMed: 26216905].
  • 4. Kandpal M, Samal J, Biswas B, Negi A, Mishra VC, Tyagi N, et al. Enhanced hepatitis B virus (HBV) pre-genomic RNA levels and higher transcription efficiency of defective HBV genomes. J Gen Virol. 2015;96(10):3109-17. doi: 10.1099/jgv.0.000256. [PubMed: 26242411].
  • 5. Wang J, Shen T, Huang X, Kumar GR, Chen X, Zeng Z, et al. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound. J Hepatol. 2016;65(4):700-10. doi: 10.1016/j.jhep.2016.05.029. [PubMed: 27245431].
  • 6. Kock J, Theilmann L, Galle P, Schlicht HJ. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology. 1996;23(3):405-13. doi: 10.1002/hep.510230303. [PubMed: 8617418].
  • 7. Su Q, Wang SF, Chang TE, Breitkreutz R, Hennig H, Takegoshi K, et al. Circulating hepatitis B virus nucleic acids in chronic infection : representation of differently polyadenylated viral transcripts during progression to nonreplicative stages. Clin Cancer Res. 2001;7(7):2005-15. [PubMed: 11448918].
  • 8. Tsuge M, Murakami E, Imamura M, Abe H, Miki D, Hiraga N, et al. Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients. J Gastroenterol. 2013;48(10):1188-204. doi: 10.1007/s00535-012-0737-2. [PubMed: 23397114].
  • 9. van Bommel F, Bartens A, Mysickova A, Hofmann J, Kruger DH, Berg T, et al. Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors. Hepatology. 2015;61(1):66-76. doi: 10.1002/hep.27381. [PubMed: 25132147].
  • 10. Hatakeyama T, Noguchi C, Hiraga N, Mori N, Tsuge M, Imamura M, et al. Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine. Hepatology. 2007;45(5):1179-86. doi: 10.1002/hep.21581. [PubMed: 17465002].
  • 11. Huang YW, Takahashi S, Tsuge M, Chen CL, Wang TC, Abe H, et al. On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy. Antivir Ther. 2015;20(4):369-75. doi: 10.3851/IMP2777. [PubMed: 24739420].
  • 12. Su M, Xiang K, Li Y, Li Y, Deng J, Xu X, et al. Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2. Infect Genet Evol. 2016;40:275-81. doi: 10.1016/j.meegid.2016.03.019. [PubMed: 27006281].
  • 13. Liang X, Cheng J, Sun Y, Chen X, Li T, Wang H, et al. Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients. J Gastroenterol Hepatol. 2015;30(4):748-55. doi: 10.1111/jgh.12835. [PubMed: 25352300].
  • 14. Chinese Society of H, Chinese Society of Infectious Diseases CMA. [The guideline of prevention and treatment for chronic hepatitis B (2010 version)]. Zhonghua Gan Zang Bing Za Zhi. 2011;19(1):13-24. doi: 10.3760/cma.j.issn.1007-3418.2011.01.007. [PubMed: 21272453].
  • 15. Liu B, Yang JX, Yan L, Zhuang H, Li T. Novel HBV recombinants between genotypes B and C in 3'-terminal reverse transcriptase (RT) sequences are associated with enhanced viral DNA load, higher RT point mutation rates and place of birth among Chinese patients. Infect Genet Evol. 2018;57:26-35. doi: 10.1016/j.meegid.2017.10.023. [PubMed: 29111272].
  • 16. Gao Y, Li Y, Meng Q, Zhang Z, Zhao P, Shang Q, et al. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?. J Clin Microbiol. 2017;55(10):2972-82. doi: 10.1128/JCM.00760-17. [PubMed: 28747369].
  • 17. Huang YW, Chayama K, Tsuge M, Takahashi S, Hatakeyama T, Abe H, et al. Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B. Antivir Ther. 2010;15(2):177-84. doi: 10.3851/IMP1508. [PubMed: 20386072].
  • 18. Yan CH, Zhao CY, Ding H, Peng YQ, Jin PY, Yan L, et al. Hepatitis B virus basal core promoter mutations A1762T/G1764A are associated with genotype C and a low serum HBsAg level in chronically-infected HBeAg-positive Chinese patients. Antiviral Res. 2012;96(2):108-14. doi: 10.1016/j.antiviral.2012.08.009. [PubMed: 22960603].
  • 19. Peng Y, Liu B, Hou J, Sun J, Hao R, Xiang K, et al. Naturally occurring deletions/insertions in HBV core promoter tend to decrease in hepatitis B e antigen-positive chronic hepatitis B patients during antiviral therapy. Antivir Ther. 2015;20(6):623-32. doi: 10.3851/IMP2955. [PubMed: 25838313].
  • 20. Hu J, Liu K. Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application. Viruses. 2017;9(3). doi: 10.3390/v9030056. [PubMed: 28335554].
  • 21. Wang HB, Wang QY, Yuan Q, Shan XY, Fu GH. Alanine aminotransferase is more sensitive to the decrease in hepatitis B virus-DNA load than other liver markers in chronic hepatitis B patients. J Clin Lab Anal. 2017;31(6). doi: 10.1002/jcla.22141. [PubMed: 28116822].
  • 22. Tong S, Revill P. Overview of hepatitis B viral replication and genetic variability. J Hepatol. 2016;64(1 Suppl):S4-S16. doi: 10.1016/j.jhep.2016.01.027. [PubMed: 27084035].
  • 23. Sozzi V, Walsh R, Littlejohn M, Colledge D, Jackson K, Warner N, et al. In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes. J Virol. 2016;90(22):10054-64. doi: 10.1128/JVI.01293-16. [PubMed: 27512071].
  • 24. Halgand B, Desterke C, Riviere L, Fallot G, Sebagh M, Calderaro J, et al. Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant. Hepatology. 2018;67(1):86-96. doi: 10.1002/hep.29463. [PubMed: 28802063].
  • 25. Wang J, Yu Y, Li G, Shen C, Meng Z, Zheng J, et al. Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients. J Hepatol. 2017. doi: 10.1016/j.jhep.2017.08.021. [PubMed: 28870671].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments